Clastogenic plasma factors: a short overview
- PMID: 20020152
- DOI: 10.1007/s00411-009-0259-3
Clastogenic plasma factors: a short overview
Abstract
A large number of studies have revealed that irradiated subjects produce soluble factors found in their blood plasma which, when transferred into cell cultures from non-irradiated individuals, show clastogenic (chromosome breaking) activity. Increased yields of chromatid-type aberrations have been characteristic in most of these studies. Exposed cohorts of various origins have revealed to possess this feature: from A-bomb survivors to patients treated with radiotherapy. It is apparent that the plasma factors are sustainable for long time periods. On the other hand, they seem to be produced very fast after exposure. Considerable variation in the effect has been found between individuals with similar radiation exposure. Further, the phenomenon is not restricted to irradiated populations. Clastogenic plasma has also been observed in patients with inflammatory diseases or congenital chromosome breakage syndromes as well in subjects exposed to other agents than ionizing radiation. Chromosomal aberration inducing substances have been detected not only in vivo, but also in vitro. A common feature to all the conditions is that they are associated with oxidative stress. Studies on the biochemical nature of the clastogenic factor(s) have been conducted, and tumor necrosis factor alpha and lipid peroxidation products, among others, have been suggested as good candidates. The relevance of the plasma factors to health effects remains open. The aim of the paper is to give a short overview on the phenomenon of clastogenic factors--their occurrence and formation as well as possible effectors.
Similar articles
-
Search for clastogenic factors in the plasma of locally irradiated individuals.Radiat Res. 2012 Mar;177(3):298-306. doi: 10.1667/rr2721.1. Epub 2011 Dec 13. Radiat Res. 2012. PMID: 22165823
-
Clastogenic factors in plasma of HIV-1 infected patients.Free Radic Biol Med. 1995 Dec;19(6):843-8. doi: 10.1016/0891-5849(95)00051-x. Free Radic Biol Med. 1995. PMID: 8582657
-
Clastogenic factors in the plasma of children exposed at Chernobyl.Mutat Res. 1997 Jan 3;373(1):47-54. doi: 10.1016/s0027-5107(96)00187-x. Mutat Res. 1997. PMID: 9015152
-
Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects.Radiat Res. 2003 May;159(5):581-96. doi: 10.1667/0033-7587(2003)159[0581:nadeoe]2.0.co;2. Radiat Res. 2003. PMID: 12710869 Review.
-
LSD and genetic damage.Science. 1971 Apr 30;172(3982):431-40. doi: 10.1126/science.172.3982.431. Science. 1971. PMID: 4994465 Review.
Cited by
-
Late health effects of ionizing radiation: bridging the experimental and epidemiological divide.Radiat Environ Biophys. 2010 May;49(2):109-10. doi: 10.1007/s00411-010-0273-5. Epub 2010 Mar 6. Radiat Environ Biophys. 2010. PMID: 20213137 No abstract available.
-
TRP Channel Involvement in Salivary Glands-Some Good, Some Bad.Cells. 2018 Jul 11;7(7):74. doi: 10.3390/cells7070074. Cells. 2018. PMID: 29997338 Free PMC article. Review.
-
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose.Int J Mol Sci. 2025 Jul 20;26(14):6968. doi: 10.3390/ijms26146968. Int J Mol Sci. 2025. PMID: 40725216 Free PMC article. Review.
-
High dose bystander effects in spatially fractionated radiation therapy.Cancer Lett. 2015 Jan 1;356(1):52-7. doi: 10.1016/j.canlet.2013.10.032. Epub 2013 Nov 15. Cancer Lett. 2015. PMID: 24246848 Free PMC article. Review.
-
Non-targeted effects of ionising radiation--implications for low dose risk.Mutat Res. 2013 Apr-Jun;752(2):84-98. doi: 10.1016/j.mrrev.2012.12.001. Epub 2012 Dec 20. Mutat Res. 2013. PMID: 23262375 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources